Metraipolis › archive › dc_6dfac2eabb1b
Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study — Europe PMC PMID:41566054
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41566054
- DOI
- 10.1007/s00277-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T13:48:23.209Z
- SHA-256 of the archived text
c4eff58827993f1b9a8b20bc70676d211256506b41f4f196382a847128b6b149- Stable URL of this page
https://metraipolis.com/documento/dc_6dfac2eabb1b
How to cite
Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study — Europe PMC PMID:41566054 — Europe PMC (en), https://europepmc.org/article/MED/41566054 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6dfac2eabb1b (Metraipolis archive dc_6dfac2eabb1b, sha256 c4eff58827993f1b9a8b20bc70676d211256506b41f4f196382a847128b6b149)
BibTeX
@misc{dc6dfac2eabb1b,
title = {Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study — Europe PMC PMID:41566054},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41566054},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6dfac2eabb1b; sha256 c4eff58827993f1b9a8b20bc70676d211256506b41f4f196382a847128b6b149},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41566054. Agents can read the archived copy with the MCP tool read_document.